Mdma molecule:

Image from PubChem

Mdma Clinical Trials

Acute Effects of R- and S-MDMA in Healthy Subjects

To see complete record on, please visit this link

Id: NCT05277636

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Recruiting

Start Date: October 1, 2022

Last Update: November 2, 2022

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: Racemic ±3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to others. These acute subjective effects of MDMA may be helpful to assist psychotherapy and MDMA is currently investigated in phase 3 trials as a possible treatment in post-traumatic stress disorder.

  • Healthy

Total execution time in seconds: 0.19932293891907